← Back
$RNA All transactions

Avidity Biosciences, Inc.

▼ SELL 10b5-1 Plan

$ Value

$2.5M

Shares

50,000

Price

$50

Filed

Sep 5

Insider

Name

Boyce Sarah

Title

President and CEO

CIK

0001629383

Roles

Director Officer

Transaction Details

Transaction Date

2025-09-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

305,871

Footnotes

The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted on August 15, 2024 by the Reporting Person. | This represents a weighted-average price. These shares were sold in multiple transactions at prices ranging from $49.76 to $50.12. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | This option award is fully vested and exercisable as of the date hereof.

Filing Info

Accession No.

0001599901-25-000175

Form Type

4

Issuer CIK

0001599901

Boyce Sarah's History

Date Ticker Type Value
2025-09-05 RNA M $62K
2025-09-05 RNA $2.5M
2025-09-05 RNA M $0
2025-08-28 RNA M $31K
2025-08-28 RNA $1.2M
2025-08-28 RNA M $0
2025-06-26 CTNM A $0

Other Insiders at RNA (90d)

No other insider activity at this issuer in the last 90 days.